Last updated: April 24, 2026

Application No. 19/303,091

Untitled Application

Unknown

Filed

1600

Examiner

HABTE, KAHSAY

Art Unit

1624

Tech Center

C4 THERAPEUTICS, INC.

Assignee

C4 Therapeutics Inc.

OA Round

1 (Non-Final)

Interview Optional

— +7.3% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1590 resolved cases, 2023–2026

Examiner Intelligence

HABTE, KAHSAY View full profile →

Grants 85% — above average

Career Allow Rate

1349 granted / 1590 resolved

+24.8% vs TC avg

Moderate +7% lift

Without

With

+7.3%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 11m

Avg Prosecution

44 currently pending

Career history

1634

Total Applications

across all art units

Statute-Specific Performance

§101

1.7%

-38.3% vs TC avg

§103

6.8%

-33.2% vs TC avg

§102

18.9%

-21.1% vs TC avg

§112

47.0%

+7.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1590 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/642,602

Patent 12605450

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

2y 5m to grant Granted Apr 21, 2026

17/288,146

Patent 12590073

NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS

2y 5m to grant Granted Mar 31, 2026

17/625,836

Patent 12590067

HERBICIDAL CYCLOHEXANEDIONE DERIVATIVES

2y 5m to grant Granted Mar 31, 2026

17/928,949

Patent 12583866

PYRIDO[2,3-B][1,4]OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4]OXAZEPINES AS IAP ANTAGONISTS

2y 5m to grant Granted Mar 24, 2026

17/500,486

Patent 12576040

IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF

2y 5m to grant Granted Mar 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

85%

Grant Probability

92%

With Interview (+7.3%)

1y 11m

Median Time to Grant

Low

PTA Risk

Based on 1590 resolved cases by this examiner. Grant probability derived from career allow rate.